display
In the dispute over vaccine deliveries, the EU Commission demands insight into the data of the pharmaceutical company Astra Zeneca.
"The EU requires information from the company by January 29th at the latest, why it wants to deliver fewer vaccine doses to the EU," said EU Commission circles in the evening after another meeting of company representatives with members of the EU states.
The contract provides for pre-production of cans in the high millions not only for the current quarter, but as early as the fourth quarter of 2020. In addition, the contract with the British-Swedish company of the EU guarantees access to the company's production data.
“Therefore, the commission now wants to use data to look at what was produced in which plant and when,” it said in commission circles.
In addition, the Astra-Zeneca vaccine could only be approved in Europe for under-65s.
As the "Handelsblatt" reported, referring to government circles, the average shows an effectiveness of eight percent for people over 65.
In the case of “Bild”, citing government circles, the effectiveness in this group was less than ten percent.
display
The federal government expects that the group will therefore only receive approval from the EU drug authority EMA for under-65s.
It is assumed that this step will take place on Friday, and the first deliveries are expected from February 15th.
Astra Zeneca initially gave no comment.
The pharmaceutical company later announced to the Reuters news agency that it would reject reports that its vaccine had been reduced to eight percent effectiveness in seniors.
The information is completely wrong.
All developments on Corona in the live ticker: